KCE methodology; National initiative; Quality indicators; Uterine cancer; Validation; Belgium; Female; Gynecology/standards; Humans; Medical Oncology/standards; Quality Assurance, Health Care/methods; Quality Assurance, Health Care/standards; Quality Indicators, Health Care/standards; Quality of Health Care; Reproducibility of Results; Uterine Neoplasms/therapy; Oncology; Obstetrics and Gynecology
Abstract :
[en] [en] OBJECTIVE: Describe the methodology and selection of quality indicators (QI) to be implemented in the EFFECT (EFFectiveness of Endometrial Cancer Treatment) project. EFFECT aims to monitor the variability in Quality of Care (QoC) of uterine cancer in Belgium, to compare the effectiveness of different treatment strategies to improve the QoC and to check the internal validity of the QI to validate the impact of process indicators on outcome.
METHODS: A QI list was retrieved from literature, recent guidelines and QI databases. The Belgian Healthcare Knowledge Center methodology was used for the selection process and involved an expert's panel rating the QI on 4 criteria. The resulting scores and further discussion resulted in a final QI list. An online EFFECT module was developed by the Belgian Cancer Registry including the list of variables required for measuring the QI. Three test phases were performed to evaluate the relevance, feasibility and understanding of the variables and to test the compatibility of the dataset.
RESULTS: 138 QI were considered for further discussion and 82 QI were eligible for rating. Based on the rating scores and consensus among the expert's panel, 41 QI were considered measurable and relevant. Testing of the data collection enabled optimization of the content and the user-friendliness of the dataset and online module.
CONCLUSIONS: This first Belgian initiative for monitoring the QoC of uterine cancer indicates that the previously used QI selection methodology is reproducible for uterine cancer. The QI list could be applied by other research groups for comparison.
Disciplines :
Human health sciences: Multidisciplinary, general & others
Author, co-author :
Werbrouck, J; Belgian Cancer Registry, Koningsstraat 215 bus 7, 1210 Brussel, Belgium. Electronic address: Joke.Werbrouck@kankerregister.org
Bouche, G; Reliable Cancer Therapies, B-1853 Strombeek-Bever, Belgium
de Jonge, E; Gynecology-Obstetrics, Ziekenhuis Oost-Limburg Campus St Jan, 3600 Genk, Belgium
Jacomen, G; Anatomopathology, AZ Sint-Maarten, 2570 Duffel, Belgium
D'Hondt, V; Medical Oncology, Institut Jules Bordet, 1000 Brussels, Belgium ; Institut Régional du Cancer Montpellier, 34298 Montpellier Cedex 5, France
Denys, H; Medical Oncology, University of Ghent, University Hospital Ghent, 9000 Gent, Belgium
Van Limbergen, E; Gynecologic Oncology, University Hospital Leuven, 3000 Leuven, Belgium
De Schutter, H; Belgian Cancer Registry, 1210 Brussel, Belgium
Van Eycken, E; Belgian Cancer Registry, 1210 Brussel, Belgium
Goffin, Frédéric ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gynécologie-obstétrique (CHR) ; Gynecology-Obstetrics, Hôpital de la Citadelle, 4000 Liège, Belgium
Amant, F; Gynecologic Oncology, University Hospital Leuven, 3000 Leuven, Belgium
Language :
English
Title :
Evaluation of the quality of the management of cancer of the corpus uteri--selection of relevant quality indicators and implementation in Belgium.
M.P. Curado, P. Edwards, H.R. Shin, H. Storm, J. Ferlay, and M. Heanue Cancer incidence in five continents IARC Sci Publ IX 2007
F. Bray, I. Dos Santos Silva, H. Moller, and E. Weiderpass Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention Cancer Epidemiol Biomarkers Prev 14 2005 1132 1142
Cancer incidence in Belgium 2008 2011 Belgian Cancer Registry Brussels [Available on www.kankerregister.org or www.registreducancer.org]
H. Kitchener, A.M. Swart, Q. Qian, C. Amos, and M.K. Parmar Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study Lancet 373 2009 125 136
P.B. Panici, S. Basile, F. Maneschi, A.A. Lissoni, M. Signorelli, and G. Scambia Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial J Natl Cancer Inst 100 2008 1707 1716
L.H. Sobin, M.K. Gospodarowicz, and C. Wittekind TNM classification of malignant tumors 2009 Blackwell Publishing Ltd
D. Querleu, F. Planchamp, F. Narducci, P. Morice, F. Joly, and C. Genestie Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Societe Francaise d'Oncologie Gynecologique Int J Gynecol Cancer 21 2011 945 950
NCCN, National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)-Uterine Neoplasms-V.I.2011 2010 NCCN, National Comprehensive Cancer Network
N. Colombo, E. Preti, F. Landoni, S. Carinelli, A. Colombo, and C. Marini Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 22 Suppl. 6 2011 vi35 vi39
S. Nagase, H. Katabuchi, M. Hiura, N. Sakuragi, Y. Aoki, and J. Kigawa Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition Int J Clin Oncol 15 2010 531 542
F. Amant, P. Moerman, P. Neven, D. Timmerman, L.E. Van, and I. Vergote Endometrial cancer Lancet 366 2005 491 505
Y. Todo, H. Kato, M. Kaneuchi, H. Watari, M. Takeda, and N. Sakuragi Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis Lancet 375 2010 1165 1172
B. Sorbe, B. Nordstrom, J. Maenpaa, J. Kuhelj, D. Kuhelj, and S. Okkan Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study Int J Gynecol Cancer 19 2009 873 878
R.A. Nout, V.T. Smit, H. Putter, I.M. Jurgenliemk-Schulz, J.J. Jobsen, and L.C. Lutgens Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Lancet 375 2010 816 823
R.A. Nout, L.V. van de Poll-Franse, M.L. Lybeert, C.C. Warlam-Rodenhuis, J.J. Jobsen, and J.W. Mens Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial J Clin Oncol 29 2011 1692 1700
M. Brzakowski, R. Fauvet, J. Gondry, and E. Darai Endometrial cancer: survey of surgical practice in France in 2008 J Gynecol Obstet Biol Reprod (Paris) 39 2010 409 417
J.S. Kwon, M.S. Carey, E.F. Cook, F. Qiu, and L. Paszat Patterns of practice and outcomes in intermediate-and high-risk stage I and II endometrial cancer: a population-based study Int J Gynecol Cancer 17 2007 433 440
P.T. Soliman, M. Frumovitz, W. Spannuth, M.J. Greer, S. Sharma, and K.M. Schmeler Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists Gynecol Oncol 119 2010 291 294
J.S. Kwon, J.A. Francis, F. Qiu, M.M. Weir, and H.C. Ettler When is a pathology review indicated in endometrial cancer? Obstet Gynecol 110 2007 1224 1230
C.M. Lee, B.M. Slomovitz, M. Greer, S. Sharma, M.A. Gregurich, and T. Burke Practice patterns of SGO members for stage IIIA endometrial cancer Gynecol Oncol 98 2005 77 83
R.W. Naumann, and R.L. Coleman The use of adjuvant radiation therapy in early endometrial cancer by members of the Society of Gynecologic Oncologists in 2005 Gynecol Oncol 105 2007 7 12
W. Small Jr., B.A. du, S. Bhatnagar, N. Reed, S. Pignata, and R. Potter Practice patterns of radiotherapy in endometrial cancer among member groups of the gynecologic cancer intergroup Int J Gynecol Cancer 19 2009 395 399
C.W. Redman An audit of the management of uterine malignancy within the West Midlands. West Midlands Gynaecological Oncology Group BJOG 107 2000 552 555
D.E. Parkin, Q. Warraich, D.J. Fleming, G.K. Chew, and M.E. Cruickshank An audit of the quality of endometrial cancer care in a specialised unit Scott Med J 51 2006 22 24
D. Boll, R.H. Verhoeven, M.A. van der Aa, M.L. Lybeert, J.W. Coebergh, and M.L. Janssen-Heijnen Adherence to national guidelines for treatment and outcome of endometrial cancer stage I in relation to co-morbidity in southern Netherlands 1995-2008 Eur J Cancer 47 2011 1504 1510
M.A. van Lankveld, N.C. Koot, P.H. Peeters, J.S. van Leeuwen, I.M. Jurgenliemk-Schulz, and M.A. van Eijkeren Compliance to surgical and radiation treatment guidelines in relation to patient outcome in early stage endometrial cancer J Eval Clin Pract 12 2006 196 201
M.J. Battista, E. Steiner, N. Rieks, J. Steetskamp, A. Seeger, and I. Sicking Nationwide analysis on surgical staging procedures and systemic treatment for patients with endometrial cancer in Germany Int J Gynecol Cancer 23 2013 105 112
A. Donabedian The quality of care. How can it be assessed? JAMA 260 1988 1743 1748
N. Klazinga, C. Fischer, and A.A. ten Health services research related to performance indicators and benchmarking in Europe J Health Serv Res Policy 16 Suppl. 2 2011 38 47
P. Demetter, W. Ceelen, E. Danse, K. Haustermans, A. Jouret-Mourin, and A. Kartheuser Quality of care indicators in rectal cancer Acta Gastroenterol Belg 74 2011 445 450
J. Vlayen, M. Verstreken, C. Mertens, E. Van Eycken, and F. Penninckx Assurance de qualité pour le cancer rectal-phase 2: développement et test d'un ensemble d'indicateurs de qualité 2008 Federaal Kenniscentrum voor de gezondheidszorg, Centre fédéral d'expertise des soins de santé
H. De Schutter, E. De Jonge, C. De Gendt, M. Adam, and L. Van Eycken Clinical practice for endometrial cancer in Belgium: retrospective comparison between patients treated within the Flemish Society for Obstetrics and Gynecology (VVOG) and population based data from the Belgian Cancer Registry (BCR) 37th GRELL Ascension reunion 2012
S. Stordeur, F. Vrijens, S. Devriese, K. Beirens, E.E. Van, and J. Vlayen Developing and measuring a set of process and outcome indicators for breast cancer Breast 21 2012 253 260
J. Vlayen, F. Vrijens, S. Devriese, K. Beirens, E.E. Van, and S. Stordeur Quality indicators for testicular cancer: a population-based study Eur J Cancer 48 2012 1133 1140
J. Vlayen, C. De Gendt, S. Stordeur, V. Schillemans, C. Camberlin, and F. Vrijens Quality indicators for the management of upper gastrointestinal cancer (KCE Report 200, Good Clinical Practice) 2013 Belgian Health Care Knowledge Centre (KCE) Brussels
D.E. Cohn, M. Leitao, C. Levenback, R. Berkowitz, L. Roman, and J. Lucci Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative Gynecol Oncol 130 2013 403 406
Accessible via www.kankerregister.org/wbcr/
www.registreducancer.org/wbcr/.
R. Salani, F.J. Backes, F.M. Fung Kee, C.H. Holschneider, L.P. Parker, and R.E. Bristow Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations Am J Obstet Gynecol 204 2011 466 478
